Lenz Therapeutics Inc (LENZ) Stock Price, Quote & News

Company Profile

LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, Cal...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 925 7000

Website: www.lenz-tx.com

Address:

201 Lomas Santa Fe Drive, Suite 300, Solana Beach, United States

LiquidThetaLEAPS Oct. 26 at 5:20 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LENZ Current Share Price: $31.97 Contracts: $LENZ January 15, 2027 $35 Calls Scale in: $9.81- $11.99 Scale out: $15.26-$19.62 Can Easily Capture: 60% ROI Blended DTE: 447 Days | Join Elites here: https://liquidtheta.com

0 · Reply

kobs210 Oct. 25 at 5:30 AM

$LENZ its hard to get but i’m in!

0 · Reply

AlexSwiss77 Oct. 24 at 9:10 PM

$LENZ I added too early on 38$ but will add again on 32$ area we are sitting on the MA200 on the daily is getting a real good base

0 · Reply

LiquidThetaLEAPS Oct. 24 at 2:56 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $LENZ Current Share Price: $32.26 Contracts: $LENZ January 15, 2027 $35 Calls Scale in: $9.47- $11.58 Scale out: $14.73-$18.95 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

InvestorWisdom Oct. 24 at 6:04 AM

$LENZ @HypnoTrader that’s why I moved to the sidelines, but it’s worth watching for a bottom/reversal at -40%…. It could be some aggressive shorts that read the reviews about having a harder time seeing in the dark etc, but they’re not looking at the complete picture. Someone could just use this the am and let it wear off before evening. There are millions of peeps that have to put their readers on and off all day at work + lose them. This would be a great solution. It doesn’t have to be perfect and used by everyone to make lots of money This is why I’m researching reviews. I’ve seen similar trading action on many stocks that went on to have big moves. This story is still young. Best of luck

0 · Reply

InvestorWisdom Oct. 24 at 5:49 AM

$LENZ review from an optometrist… https://x.com/icarethoughts4u/status/1981043935968452710?s=61&t=OjJ-Ed1n4SIjxikuY3Ej6Q

0 · Reply

InvestorWisdom Oct. 24 at 5:44 AM

$LENZ https://youtube.com/shorts/kzbqFDY8qsU?si=JbtZMZo5zkEbE5EW

0 · Reply

InvestorWisdom Oct. 24 at 5:29 AM

$LENZ I got stopped out at higher levels, but looking to buy back in once it bottoms, which could be here at the 200DMA… At $900 million valuation it should see a nice uptrend once revenues start to rise. Vizz won’t be for everyone but the market is large. A small slice can be very profitable being a consumable product.

1 · Reply

CCB31 Oct. 23 at 9:10 PM

$LENZ my goodness, this stock went down every single day non stop for 3 weeks with no bad news. Many analysts rate this stock a buy. I am so tired of this down trend. What happen?

1 · Reply

Max_Regards Oct. 23 at 1:43 PM

$LENZ pickleball will pump this drug, think about it. Old people love pickleball. This drop improves close rebate eye sight by age related farsightedness. This will improve their pickleball game! VIZZ needs to be a lead sponsor of pickleball.

1 · Reply

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

Sep 30, 2025, 8:00 AM EDT - 25 days ago

LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States

Sep 10, 2025, 3:05 PM EDT - 6 weeks ago

LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 2:49 PM EDT - 7 weeks ago

LENZ Therapeutics, Inc. (LENZ) Therapeutics, Inc. Presents At Citi's Biopharma Back To School Conference Transcript

Aug 25, 2025, 8:00 AM EDT - 2 months ago

LENZ Therapeutics to Present at Upcoming Investor and Medical Conferences

Jul 31, 2025, 4:05 PM EDT - 3 months ago

LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment of Presbyopia

Jul 30, 2025, 8:00 AM EDT - 3 months ago

LENZ Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Jul 29, 2025, 1:32 PM EDT - 3 months ago

LENZ Therapeutics: Undervalued Ahead Of PDUFA

Jul 28, 2025, 8:00 AM EDT - 3 months ago

LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia

Jul 7, 2025, 8:00 AM EDT - 3 months ago

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada

Jul 1, 2025, 4:23 PM EDT - 4 months ago

LENZ Therapeutics: Presbyopia Eyedrops Look Promising

May 27, 2025, 8:00 AM EDT - 5 months ago

LENZ Therapeutics to Present at Upcoming Investor Conferences

May 9, 2025, 10:33 AM EDT - 6 months ago

LENZ Therapeutics, Inc. (LENZ) Q1 2025 Earnings Call Transcript

May 9, 2025, 9:03 AM EDT - 6 months ago

LENZ Therapeutics and Lotus Pharmaceutical Announce Exclusive License and Commercialization Agreement for LNZ100 in the Republic of Korea and Southeast Asia

May 7, 2025, 4:05 PM EDT - 6 months ago

LENZ Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 6, 2025, 4:30 PM EDT - 6 months ago

LENZ Therapeutics to Participate in Upcoming BofA Securities 2025 Health Care Conference

Apr 30, 2025, 4:30 PM EDT - 6 months ago

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

Apr 7, 2025, 8:00 AM EDT - 7 months ago

LENZ Therapeutics: Freedom From Reading Glasses

Mar 27, 2025, 5:33 PM EDT - 7 months ago

LENZ Therapeutics Stock Is Attractive Before PDUFA

Mar 19, 2025, 8:09 PM EDT - 7 months ago

LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:05 PM EDT - 7 months ago

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights

Mar 11, 2025, 8:00 AM EDT - 8 months ago

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025

Mar 3, 2025, 8:00 AM EST - 8 months ago

LENZ Therapeutics to Host Commercial Day on April 15, 2025

Feb 24, 2025, 8:00 AM EST - 8 months ago

LENZ Therapeutics to Participate in Upcoming Investor Conferences

Nov 6, 2024, 11:43 AM EST - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 1:51 PM EDT - 1 year ago

LENZ Therapeutics' Investigational Drug For Age-Related Blindness Aces Pivotal China Trial, Analyst Says Data Readout May Strengthen Position For Ex-U.S. Partnerships

Oct 27, 2024, 9:00 PM EDT - 1 year ago

CORXEL and LENZ Therapeutics Announce Positive Topline Data from China Phase 3 Presbyopia Trial of LNZ100

Oct 21, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

ABOS

Aug 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics: Upcoming PDUFA, Strong Data, Some Risks

Aug 16, 2024, 7:43 PM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

LENZ Therapeutics Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of Presbyopia

Aug 7, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024

Jun 10, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024

May 30, 2024, 8:00 AM EDT - 1 year ago

LENZ Therapeutics to Present at the Jefferies Global Healthcare Conference

May 11, 2024, 7:26 AM EDT - 1 year ago

LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 1, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024

Apr 3, 2024, 7:49 AM EDT - 1 year ago

Lenz Therapeutics' eye disease drugs meet main goal of late-stage study

Apr 3, 2024, 7:00 AM EDT - 1 year ago

LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia Trials

Apr 2, 2024, 4:01 PM EDT - 1 year ago

LENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia Trials

Mar 21, 2024, 4:30 PM EDT - 1 year ago

LENZ Therapeutics Announces Completion of Merger with Graphite Bio and Provides Update on Recent Clinical and Corporate Progress

LiquidThetaLEAPS Oct. 26 at 5:20 AM

0 · Reply

kobs210 Oct. 25 at 5:30 AM

$LENZ its hard to get but i’m in!

0 · Reply

AlexSwiss77 Oct. 24 at 9:10 PM

$LENZ I added too early on 38$ but will add again on 32$ area we are sitting on the MA200 on the daily is getting a real good base

0 · Reply

LiquidThetaLEAPS Oct. 24 at 2:56 PM

0 · Reply

InvestorWisdom Oct. 24 at 6:04 AM

0 · Reply

InvestorWisdom Oct. 24 at 5:49 AM

$LENZ review from an optometrist… https://x.com/icarethoughts4u/status/1981043935968452710?s=61&t=OjJ-Ed1n4SIjxikuY3Ej6Q

0 · Reply

InvestorWisdom Oct. 24 at 5:44 AM

$LENZ https://youtube.com/shorts/kzbqFDY8qsU?si=JbtZMZo5zkEbE5EW

0 · Reply

InvestorWisdom Oct. 24 at 5:29 AM

1 · Reply

CCB31 Oct. 23 at 9:10 PM

$LENZ my goodness, this stock went down every single day non stop for 3 weeks with no bad news. Many analysts rate this stock a buy. I am so tired of this down trend. What happen?

1 · Reply

Max_Regards Oct. 23 at 1:43 PM

1 · Reply

Max_Regards Oct. 23 at 1:40 PM

$LENZ

2 · Reply

Max_Regards Oct. 23 at 10:55 AM

$LENZ

0 · Reply

Max_Regards Oct. 23 at 10:53 AM

$LENZ

0 · Reply